Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
8001
8002
8003
8004
8005
8006
8007
8008
8009
8010
8011
8012
8013
8014
8015
8016
8017
8018
8019
8020
8021
8022
8023
8024
8025
8026
8027
8028
8029
8030
8031
8032
8033
8034
8035
8036
8037
8038
8039
8040
8041
8042
8043
8044
8045
8046
8047
8048
8049
8050
8051
8052
8053
8054
8055
8056
8057
8058
8059
8060
8061
8062
8063
8064
8065
8066
8067
8068
8069
8070
8071
8072
8073
8074
8075
8076
8077
8078
8079
8080
8081
8082
8083
8084
8085
8086
8087
8088
8089
8090
8091
8092
8093
8094
8095
8096
8097
8098
8099
8100
8101
8102
8103
8104
8105
8106
8107
8108
8109
8110
8111
8112
8113
8114
8115
8116
8117
8118
8119
8120
8121
8122
8123
8124
8125
8126
8127
8128
8129
8130
8131
8132
8133
8134
8135
8136
8137
8138
8139
8140
8141
8142
8143
8144
8145
8146
8147
8148
8149
8150
8151
8152
8153
8154
8155
8156
8157
8158
8159
8160
8161
8162
8163
8164
8165
8166
8167
8168
8169
8170
8171
8172
8173
8174
8175
8176
8177
8178
8179
8180
8181
8182
8183
8184
8185
8186
8187
8188
8189
8190
8191
8192
8193
8194
8195
8196
8197
8198
8199
8200
| UnnamedSample_HQ_transcript/72606|m.18404 | UnnamedSample_HQ_transcript/72606 | Coverage 0.338 too low. | 4a6b9921f5fc87315b9667b5e120a3bb | 290 | Pfam | PF00194 | Eukaryotic-type carbonic anhydrase | 47 | 285 | 2.4E-60 | T | 22-09-2020 | IPR001148 | Alpha carbonic anhydrase domain |
| UnnamedSample_HQ_transcript/21602|m.7310 | UnnamedSample_HQ_transcript/21602 | Coverage 0.963 too low. | 17babbe986908e630376eea31528274d | 684 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 91 | 653 | 8.5E-198 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
| UnnamedSample_HQ_transcript/81445|m.19948 | UnnamedSample_HQ_transcript/81445 | Coverage 0.655 too low. | a1505f0c4c7fffa9b768c3d24d11f228 | 303 | Pfam | PF00337 | Galactoside-binding lectin | 14 | 142 | 4.4E-31 | T | 22-09-2020 | IPR001079 | Galectin, carbohydrate recognition domain |
| UnnamedSample_HQ_transcript/86726|m.20761 | UnnamedSample_HQ_transcript/86726 | Coverage 0.621 too low. | a1505f0c4c7fffa9b768c3d24d11f228 | 303 | Pfam | PF00337 | Galactoside-binding lectin | 14 | 142 | 4.4E-31 | T | 22-09-2020 | IPR001079 | Galectin, carbohydrate recognition domain |
| UnnamedSample_HQ_transcript/118274|m.24702 | UnnamedSample_HQ_transcript/118274 | Coverage 0.987 too low. | 1ef8f974376ee4a76cfa18d689c14ff7 | 171 | Pfam | PF00810 | ER lumen protein retaining receptor | 1 | 128 | 3.7E-46 | T | 22-09-2020 | IPR000133 | ER lumen protein retaining receptor |
| UnnamedSample_HQ_transcript/72638|m.18408 | UnnamedSample_HQ_transcript/72638 | Coverage 0.833 too low. | 16772789b81cf29b5c687a80959140fd | 359 | Pfam | PF00307 | Calponin homology (CH) domain | 207 | 304 | 7.2E-14 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/72638|m.18408 | UnnamedSample_HQ_transcript/72638 | Coverage 0.833 too low. | 16772789b81cf29b5c687a80959140fd | 359 | Pfam | PF00307 | Calponin homology (CH) domain | 81 | 184 | 3.6E-23 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/27565|m.8848 | UnnamedSample_HQ_transcript/27565 | Coverage 0.902 too low. | a9c5a1bc1981fd5fa2d65017dbdaf063 | 623 | Pfam | PF00567 | Tudor domain | 402 | 520 | 1.4E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/37915|m.11379 | UnnamedSample_HQ_transcript/37915 | Coverage 0.642 too low. | f1d4ddde4f8dd9ba4666e61c6fc30bca | 431 | Pfam | PF02984 | Cyclin, C-terminal domain | 61 | 134 | 5.2E-5 | T | 22-09-2020 | IPR004367 | Cyclin, C-terminal domain |
| UnnamedSample_HQ_transcript/113727|m.24265 | UnnamedSample_HQ_transcript/113727 | Coverage 0.772 too low. | 30a96af8ea0e9f123782c7afa085450c | 229 | Pfam | PF13522 | Glutamine amidotransferase domain | 78 | 201 | 5.1E-20 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 688 | 708 | 0.01 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 393 | 437 | 2.2E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 723 | 769 | 3.1E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 440 | 490 | 5.2E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 772 | 817 | 3.9E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 827 | 875 | 5.1E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 984 | 1027 | 5.4E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 936 | 981 | 1.4E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 337 | 384 | 1.6E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 276 | 324 | 6.8E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 882 | 933 | 7.4E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00052 | Laminin B (Domain IV) | 556 | 687 | 9.8E-27 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/14380|m.5228 | UnnamedSample_HQ_transcript/14380 | Identity 0.874 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 41 | 273 | 8.5E-69 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 688 | 708 | 0.01 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 393 | 437 | 2.2E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 723 | 769 | 3.1E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 440 | 490 | 5.2E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 772 | 817 | 3.9E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 827 | 875 | 5.1E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 984 | 1027 | 5.4E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 936 | 981 | 1.4E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 337 | 384 | 1.6E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 276 | 324 | 6.8E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00053 | Laminin EGF domain | 882 | 933 | 7.4E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00052 | Laminin B (Domain IV) | 556 | 687 | 9.8E-27 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/10625|m.4032 | UnnamedSample_HQ_transcript/10625 | Identity 0.884 too low. | d6b6e7e139942ffd67d977b826e8f8db | 1203 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 41 | 273 | 8.5E-69 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/9973|m.3818 | UnnamedSample_HQ_transcript/9973 | Coverage 0.811 too low. | b0898dabb29faa68649fcfa6896461c6 | 1215 | Pfam | PF00063 | Myosin head (motor domain) | 90 | 766 | 1.5E-284 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/9973|m.3818 | UnnamedSample_HQ_transcript/9973 | Coverage 0.811 too low. | b0898dabb29faa68649fcfa6896461c6 | 1215 | Pfam | PF02736 | Myosin N-terminal SH3-like domain | 36 | 75 | 3.0E-12 | T | 22-09-2020 | IPR004009 | Myosin, N-terminal, SH3-like |
| UnnamedSample_HQ_transcript/9973|m.3818 | UnnamedSample_HQ_transcript/9973 | Coverage 0.811 too low. | b0898dabb29faa68649fcfa6896461c6 | 1215 | Pfam | PF01576 | Myosin tail | 846 | 1214 | 2.8E-57 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/88322|m.20986 | UnnamedSample_HQ_transcript/88322 | Coverage 0.679 too low. | d3239c5b590c6dc02b7b967220db4d03 | 418 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 124 | 418 | 1.3E-59 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/71607|m.18226 | UnnamedSample_HQ_transcript/71607 | Coverage 0.831 too low. | c672ca62aedd7c88c2b2446ef0a6aef5 | 474 | Pfam | PF00083 | Sugar (and other) transporter | 32 | 469 | 3.6E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/17553|m.6179 | UnnamedSample_HQ_transcript/17553 | Identity 0.685 too low. | 0c31707be382749ab0be20dd191db4fa | 1129 | Pfam | PF00176 | SNF2 family N-terminal domain | 609 | 897 | 1.0E-72 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/17553|m.6179 | UnnamedSample_HQ_transcript/17553 | Identity 0.685 too low. | 0c31707be382749ab0be20dd191db4fa | 1129 | Pfam | PF00271 | Helicase conserved C-terminal domain | 926 | 1039 | 1.3E-19 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/17553|m.6179 | UnnamedSample_HQ_transcript/17553 | Identity 0.685 too low. | 0c31707be382749ab0be20dd191db4fa | 1129 | Pfam | PF08880 | QLQ | 87 | 121 | 9.0E-10 | T | 22-09-2020 | IPR014978 | Glutamine-Leucine-Glutamine, QLQ |
| UnnamedSample_HQ_transcript/17553|m.6179 | UnnamedSample_HQ_transcript/17553 | Identity 0.685 too low. | 0c31707be382749ab0be20dd191db4fa | 1129 | Pfam | PF07533 | BRK domain | 482 | 522 | 7.7E-14 | T | 22-09-2020 | IPR006576 | BRK domain |
| UnnamedSample_HQ_transcript/17553|m.6179 | UnnamedSample_HQ_transcript/17553 | Identity 0.685 too low. | 0c31707be382749ab0be20dd191db4fa | 1129 | Pfam | PF07529 | HSA | 339 | 409 | 1.4E-17 | T | 22-09-2020 | IPR014012 | Helicase/SANT-associated domain |
| UnnamedSample_HQ_transcript/15732|m.5625 | UnnamedSample_HQ_transcript/15732 | Identity 0.683 too low. | 0c31707be382749ab0be20dd191db4fa | 1129 | Pfam | PF00176 | SNF2 family N-terminal domain | 609 | 897 | 1.0E-72 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/15732|m.5625 | UnnamedSample_HQ_transcript/15732 | Identity 0.683 too low. | 0c31707be382749ab0be20dd191db4fa | 1129 | Pfam | PF00271 | Helicase conserved C-terminal domain | 926 | 1039 | 1.3E-19 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/15732|m.5625 | UnnamedSample_HQ_transcript/15732 | Identity 0.683 too low. | 0c31707be382749ab0be20dd191db4fa | 1129 | Pfam | PF08880 | QLQ | 87 | 121 | 9.0E-10 | T | 22-09-2020 | IPR014978 | Glutamine-Leucine-Glutamine, QLQ |
| UnnamedSample_HQ_transcript/15732|m.5625 | UnnamedSample_HQ_transcript/15732 | Identity 0.683 too low. | 0c31707be382749ab0be20dd191db4fa | 1129 | Pfam | PF07533 | BRK domain | 482 | 522 | 7.7E-14 | T | 22-09-2020 | IPR006576 | BRK domain |
| UnnamedSample_HQ_transcript/15732|m.5625 | UnnamedSample_HQ_transcript/15732 | Identity 0.683 too low. | 0c31707be382749ab0be20dd191db4fa | 1129 | Pfam | PF07529 | HSA | 339 | 409 | 1.4E-17 | T | 22-09-2020 | IPR014012 | Helicase/SANT-associated domain |
| UnnamedSample_HQ_transcript/11579|m.4349 | UnnamedSample_HQ_transcript/11579 | Coverage 0.739 too low. | e92213569f091922bd2e748322dd461e | 660 | Pfam | PF09380 | FERM C-terminal PH-like domain | 38 | 126 | 1.9E-24 | T | 22-09-2020 | IPR018980 | FERM, C-terminal PH-like domain |
| UnnamedSample_HQ_transcript/11579|m.4349 | UnnamedSample_HQ_transcript/11579 | Coverage 0.739 too low. | e92213569f091922bd2e748322dd461e | 660 | Pfam | PF08736 | FERM adjacent (FA) | 134 | 174 | 4.3E-14 | T | 22-09-2020 | IPR014847 | FERM adjacent (FA) |
| UnnamedSample_HQ_transcript/38676|m.11547 | UnnamedSample_HQ_transcript/38676 | Identity 0.925 too low. | f3d1b21b57abfcf3edc8cffb8afa1543 | 468 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 46 | 445 | 3.3E-63 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/47258|m.13421 | UnnamedSample_HQ_transcript/47258 | Identity 0.917 too low. | f3d1b21b57abfcf3edc8cffb8afa1543 | 468 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 46 | 445 | 3.3E-63 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/45304|m.12976 | UnnamedSample_HQ_transcript/45304 | Identity 0.887 too low. | f3d1b21b57abfcf3edc8cffb8afa1543 | 468 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 46 | 445 | 3.3E-63 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/37650|m.11310 | UnnamedSample_HQ_transcript/37650 | Identity 0.921 too low. | f3d1b21b57abfcf3edc8cffb8afa1543 | 468 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 46 | 445 | 3.3E-63 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/15850|m.5663 | UnnamedSample_HQ_transcript/15850 | Identity 0.930 too low. | f3d1b21b57abfcf3edc8cffb8afa1543 | 468 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 46 | 445 | 3.3E-63 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/53579|m.14756 | UnnamedSample_HQ_transcript/53579 | Identity 0.909 too low. | f3d1b21b57abfcf3edc8cffb8afa1543 | 468 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 46 | 445 | 3.3E-63 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/56599|m.15360 | UnnamedSample_HQ_transcript/56599 | Identity 0.909 too low. | f3d1b21b57abfcf3edc8cffb8afa1543 | 468 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 46 | 445 | 3.3E-63 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/90749|m.21369 | UnnamedSample_HQ_transcript/90749 | Coverage 0.509 too low. | 87cf19cb229e74c351428e9bee4db657 | 144 | Pfam | PF00970 | Oxidoreductase FAD-binding domain | 49 | 140 | 6.8E-27 | T | 22-09-2020 | IPR008333 | Flavoprotein pyridine nucleotide cytochrome reductase-like, FAD-binding domain |
| UnnamedSample_HQ_transcript/19827|m.6819 | UnnamedSample_HQ_transcript/19827 | Coverage 0.060 too low. | 163b613014d06006be3b158e8cbfc194 | 1014 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 318 | 368 | 1.7E-6 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/19827|m.6819 | UnnamedSample_HQ_transcript/19827 | Coverage 0.060 too low. | 163b613014d06006be3b158e8cbfc194 | 1014 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 255 | 315 | 1.8E-7 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/19827|m.6819 | UnnamedSample_HQ_transcript/19827 | Coverage 0.060 too low. | 163b613014d06006be3b158e8cbfc194 | 1014 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 55 | 123 | 1.1E-8 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/19827|m.6819 | UnnamedSample_HQ_transcript/19827 | Coverage 0.060 too low. | 163b613014d06006be3b158e8cbfc194 | 1014 | Pfam | PF00651 | BTB/POZ domain | 800 | 903 | 2.3E-15 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/19827|m.6819 | UnnamedSample_HQ_transcript/19827 | Coverage 0.060 too low. | 163b613014d06006be3b158e8cbfc194 | 1014 | Pfam | PF00651 | BTB/POZ domain | 658 | 718 | 1.8E-9 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/116912|m.24575 | UnnamedSample_HQ_transcript/116912 | Coverage 0.977 too low. | 8eb66da673f52b8148f86a7cfec854e4 | 144 | Pfam | PF08397 | IRSp53/MIM homology domain | 14 | 142 | 1.9E-21 | T | 22-09-2020 | IPR013606 | IMD/I-BAR domain |
| UnnamedSample_HQ_transcript/15889|m.5674 | UnnamedSample_HQ_transcript/15889 | Coverage 0.904 too low. | fc3451458d25b72206b544774f2ed0aa | 529 | Pfam | PF00567 | Tudor domain | 313 | 437 | 1.1E-17 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/23678|m.7855 | UnnamedSample_HQ_transcript/23678 | Coverage 0.513 too low. | b66c1f421b4d4660a9b7bc0264173467 | 909 | Pfam | PF10531 | SLBB domain | 726 | 774 | 4.9E-6 | T | 22-09-2020 | IPR019554 | Soluble ligand binding domain |
| UnnamedSample_HQ_transcript/23678|m.7855 | UnnamedSample_HQ_transcript/23678 | Coverage 0.513 too low. | b66c1f421b4d4660a9b7bc0264173467 | 909 | Pfam | PF10589 | NADH-ubiquinone oxidoreductase-F iron-sulfur binding region | 815 | 897 | 6.9E-29 | T | 22-09-2020 | IPR019575 | NADH-ubiquinone oxidoreductase 51kDa subunit, iron-sulphur binding domain |
| UnnamedSample_HQ_transcript/23678|m.7855 | UnnamedSample_HQ_transcript/23678 | Coverage 0.513 too low. | b66c1f421b4d4660a9b7bc0264173467 | 909 | Pfam | PF01512 | Respiratory-chain NADH dehydrogenase 51 Kd subunit | 529 | 699 | 2.8E-49 | T | 22-09-2020 | IPR011538 | NADH-ubiquinone oxidoreductase 51kDa subunit, FMN-binding domain |
| UnnamedSample_HQ_transcript/38644|m.11540 | UnnamedSample_HQ_transcript/38644 | Identity 0.793 too low. | 6a25e7f67d9abf3a4a51bee5d1feb766 | 681 | Pfam | PF01658 | Myo-inositol-1-phosphate synthase | 307 | 420 | 8.3E-42 | T | 22-09-2020 | IPR013021 | Myo-inositol-1-phosphate synthase, GAPDH-like |
| UnnamedSample_HQ_transcript/38644|m.11540 | UnnamedSample_HQ_transcript/38644 | Identity 0.793 too low. | 6a25e7f67d9abf3a4a51bee5d1feb766 | 681 | Pfam | PF07994 | Myo-inositol-1-phosphate synthase | 57 | 490 | 1.3E-136 | T | 22-09-2020 | IPR002587 | Myo-inositol-1-phosphate synthase |
| UnnamedSample_HQ_transcript/42238|m.12316 | UnnamedSample_HQ_transcript/42238 | Identity 0.819 too low. | 6a25e7f67d9abf3a4a51bee5d1feb766 | 681 | Pfam | PF01658 | Myo-inositol-1-phosphate synthase | 307 | 420 | 8.3E-42 | T | 22-09-2020 | IPR013021 | Myo-inositol-1-phosphate synthase, GAPDH-like |
| UnnamedSample_HQ_transcript/42238|m.12316 | UnnamedSample_HQ_transcript/42238 | Identity 0.819 too low. | 6a25e7f67d9abf3a4a51bee5d1feb766 | 681 | Pfam | PF07994 | Myo-inositol-1-phosphate synthase | 57 | 490 | 1.3E-136 | T | 22-09-2020 | IPR002587 | Myo-inositol-1-phosphate synthase |
| UnnamedSample_HQ_transcript/31118|m.9738 | UnnamedSample_HQ_transcript/31118 | Identity 0.823 too low. | 6a25e7f67d9abf3a4a51bee5d1feb766 | 681 | Pfam | PF01658 | Myo-inositol-1-phosphate synthase | 307 | 420 | 8.3E-42 | T | 22-09-2020 | IPR013021 | Myo-inositol-1-phosphate synthase, GAPDH-like |
| UnnamedSample_HQ_transcript/31118|m.9738 | UnnamedSample_HQ_transcript/31118 | Identity 0.823 too low. | 6a25e7f67d9abf3a4a51bee5d1feb766 | 681 | Pfam | PF07994 | Myo-inositol-1-phosphate synthase | 57 | 490 | 1.3E-136 | T | 22-09-2020 | IPR002587 | Myo-inositol-1-phosphate synthase |
| UnnamedSample_HQ_transcript/33234|m.10266 | UnnamedSample_HQ_transcript/33234 | Identity 0.818 too low. | 6a25e7f67d9abf3a4a51bee5d1feb766 | 681 | Pfam | PF01658 | Myo-inositol-1-phosphate synthase | 307 | 420 | 8.3E-42 | T | 22-09-2020 | IPR013021 | Myo-inositol-1-phosphate synthase, GAPDH-like |
| UnnamedSample_HQ_transcript/33234|m.10266 | UnnamedSample_HQ_transcript/33234 | Identity 0.818 too low. | 6a25e7f67d9abf3a4a51bee5d1feb766 | 681 | Pfam | PF07994 | Myo-inositol-1-phosphate synthase | 57 | 490 | 1.3E-136 | T | 22-09-2020 | IPR002587 | Myo-inositol-1-phosphate synthase |
| UnnamedSample_HQ_transcript/36588|m.11065 | UnnamedSample_HQ_transcript/36588 | Identity 0.804 too low. | 6a25e7f67d9abf3a4a51bee5d1feb766 | 681 | Pfam | PF01658 | Myo-inositol-1-phosphate synthase | 307 | 420 | 8.3E-42 | T | 22-09-2020 | IPR013021 | Myo-inositol-1-phosphate synthase, GAPDH-like |
| UnnamedSample_HQ_transcript/36588|m.11065 | UnnamedSample_HQ_transcript/36588 | Identity 0.804 too low. | 6a25e7f67d9abf3a4a51bee5d1feb766 | 681 | Pfam | PF07994 | Myo-inositol-1-phosphate synthase | 57 | 490 | 1.3E-136 | T | 22-09-2020 | IPR002587 | Myo-inositol-1-phosphate synthase |
| UnnamedSample_HQ_transcript/40681|m.12005 | UnnamedSample_HQ_transcript/40681 | Coverage 0.273 too low. | 986f929fb3f5aa4d44736e505ae48e6b | 634 | Pfam | PF09334 | tRNA synthetases class I (M) | 124 | 209 | 2.7E-9 | T | 22-09-2020 | IPR015413 | Methionyl/Leucyl tRNA synthetase |
| UnnamedSample_HQ_transcript/40681|m.12005 | UnnamedSample_HQ_transcript/40681 | Coverage 0.273 too low. | 986f929fb3f5aa4d44736e505ae48e6b | 634 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 246 | 367 | 1.7E-14 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/47777|m.13530 | UnnamedSample_HQ_transcript/47777 | Coverage 0.471 too low. | 416b65b726a51f077dde7d68b03cfbe3 | 726 | Pfam | PF16134 | THO complex subunit 2 N-terminus | 237 | 370 | 6.8E-22 | T | 22-09-2020 | IPR032302 | THO complex subunit 2, N-terminal domain |
| UnnamedSample_HQ_transcript/47777|m.13530 | UnnamedSample_HQ_transcript/47777 | Coverage 0.471 too low. | 416b65b726a51f077dde7d68b03cfbe3 | 726 | Pfam | PF16134 | THO complex subunit 2 N-terminus | 2 | 209 | 2.2E-25 | T | 22-09-2020 | IPR032302 | THO complex subunit 2, N-terminal domain |
| UnnamedSample_HQ_transcript/47777|m.13530 | UnnamedSample_HQ_transcript/47777 | Coverage 0.471 too low. | 416b65b726a51f077dde7d68b03cfbe3 | 726 | Pfam | PF11732 | Transcription- and export-related complex subunit | 372 | 447 | 6.1E-24 | T | 22-09-2020 | IPR021726 | THO complex, subunitTHOC2, N-terminal |
| UnnamedSample_HQ_transcript/47777|m.13530 | UnnamedSample_HQ_transcript/47777 | Coverage 0.471 too low. | 416b65b726a51f077dde7d68b03cfbe3 | 726 | Pfam | PF11262 | Transcription factor/nuclear export subunit protein 2 | 678 | 721 | 2.3E-9 | T | 22-09-2020 | IPR021418 | THO complex, subunitTHOC2, C-terminal |
| UnnamedSample_HQ_transcript/3067|m.1464 | UnnamedSample_HQ_transcript/3067 | Coverage 0.069 too low. | 62f7f01a865b291761b6106d940a26ab | 1581 | Pfam | PF00501 | AMP-binding enzyme | 347 | 796 | 6.4E-33 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/3067|m.1464 | UnnamedSample_HQ_transcript/3067 | Coverage 0.069 too low. | 62f7f01a865b291761b6106d940a26ab | 1581 | Pfam | PF00501 | AMP-binding enzyme | 975 | 1420 | 6.1E-59 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/3067|m.1464 | UnnamedSample_HQ_transcript/3067 | Coverage 0.069 too low. | 62f7f01a865b291761b6106d940a26ab | 1581 | Pfam | PF06464 | DMAP1-binding Domain | 9 | 70 | 5.2E-16 | T | 22-09-2020 | IPR010506 | DMAP1-binding domain |
| UnnamedSample_HQ_transcript/86477|m.20718 | UnnamedSample_HQ_transcript/86477 | Coverage 0.881 too low. | 0a48550c940f5baa32ad47a0c9d61d34 | 466 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 207 | 397 | 1.5E-42 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/86477|m.20718 | UnnamedSample_HQ_transcript/86477 | Coverage 0.881 too low. | 0a48550c940f5baa32ad47a0c9d61d34 | 466 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 88 | 156 | 2.5E-29 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/71288|m.18170 | UnnamedSample_HQ_transcript/71288 | Coverage 0.731 too low. | 0a48550c940f5baa32ad47a0c9d61d34 | 466 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 207 | 397 | 1.5E-42 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/71288|m.18170 | UnnamedSample_HQ_transcript/71288 | Coverage 0.731 too low. | 0a48550c940f5baa32ad47a0c9d61d34 | 466 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 88 | 156 | 2.5E-29 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/9775|m.3756 | UnnamedSample_HQ_transcript/9775 | Coverage 0.090 too low. | 5fe45af48df743811143ef8fcd2c2af1 | 619 | Pfam | PF00225 | Kinesin motor domain | 142 | 467 | 9.6E-97 | T | 22-09-2020 | IPR001752 | Kinesin motor domain |
| UnnamedSample_HQ_transcript/91140|m.21428 | UnnamedSample_HQ_transcript/91140 | Coverage 0.967 too low. | e2739443d3f115ff1ef0a4107a556836 | 405 | Pfam | PF11838 | ERAP1-like C-terminal domain | 12 | 311 | 2.9E-52 | T | 22-09-2020 | IPR024571 | ERAP1-like C-terminal domain |
| UnnamedSample_HQ_transcript/91516|m.21477 | UnnamedSample_HQ_transcript/91516 | Coverage 0.967 too low. | e2739443d3f115ff1ef0a4107a556836 | 405 | Pfam | PF11838 | ERAP1-like C-terminal domain | 12 | 311 | 2.9E-52 | T | 22-09-2020 | IPR024571 | ERAP1-like C-terminal domain |
| UnnamedSample_HQ_transcript/2702|m.1322 | UnnamedSample_HQ_transcript/2702 | Coverage 0.919 too low. | 05417a6ee69de3c9767f8a84c4442af3 | 1155 | Pfam | PF01576 | Myosin tail | 576 | 1116 | 2.4E-76 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/2702|m.1322 | UnnamedSample_HQ_transcript/2702 | Coverage 0.919 too low. | 05417a6ee69de3c9767f8a84c4442af3 | 1155 | Pfam | PF01576 | Myosin tail | 307 | 581 | 3.6E-32 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/2702|m.1322 | UnnamedSample_HQ_transcript/2702 | Coverage 0.919 too low. | 05417a6ee69de3c9767f8a84c4442af3 | 1155 | Pfam | PF00063 | Myosin head (motor domain) | 1 | 227 | 8.3E-72 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/63638|m.16764 | UnnamedSample_HQ_transcript/63638 | Coverage 0.514 too low. | a0a1d1d2ccefd56e1f87b5fd20ab9035 | 532 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 36 | 510 | 5.5E-94 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/82881|m.20174 | UnnamedSample_HQ_transcript/82881 | Coverage 0.541 too low. | e73a5358e16f9245a0a34762caa4db7f | 329 | Pfam | PF02210 | Laminin G domain | 4 | 130 | 1.2E-23 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/82881|m.20174 | UnnamedSample_HQ_transcript/82881 | Coverage 0.541 too low. | e73a5358e16f9245a0a34762caa4db7f | 329 | Pfam | PF02210 | Laminin G domain | 181 | 308 | 4.9E-21 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/68691|m.17706 | UnnamedSample_HQ_transcript/68691 | Coverage 0.978 too low. | 75192657f7e958649c42dba5a2a1415e | 390 | Pfam | PF13850 | Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC) | 14 | 103 | 1.1E-24 | T | 22-09-2020 | IPR039542 | Endoplasmic reticulum vesicle transporter, N-terminal |
| UnnamedSample_HQ_transcript/68691|m.17706 | UnnamedSample_HQ_transcript/68691 | Coverage 0.978 too low. | 75192657f7e958649c42dba5a2a1415e | 390 | Pfam | PF07970 | Endoplasmic reticulum vesicle transporter | 152 | 371 | 2.2E-69 | T | 22-09-2020 | IPR012936 | Endoplasmic reticulum vesicle transporter, C-terminal |
| UnnamedSample_HQ_transcript/119471|m.24810 | UnnamedSample_HQ_transcript/119471 | Coverage 0.983 too low. | 32481de9dbbf73bfd72560edca158080 | 151 | Pfam | PF13499 | EF-hand domain pair | 10 | 71 | 1.4E-9 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/119471|m.24810 | UnnamedSample_HQ_transcript/119471 | Coverage 0.983 too low. | 32481de9dbbf73bfd72560edca158080 | 151 | Pfam | PF13499 | EF-hand domain pair | 86 | 148 | 1.2E-14 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/30481|m.9581 | UnnamedSample_HQ_transcript/30481 | Coverage 0.235 too low. | 6c38b90daa1408edf999bdc1eea80558 | 527 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 438 | 514 | 4.4E-17 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/30481|m.9581 | UnnamedSample_HQ_transcript/30481 | Coverage 0.235 too low. | 6c38b90daa1408edf999bdc1eea80558 | 527 | Pfam | PF00501 | AMP-binding enzyme | 32 | 429 | 2.5E-84 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/60120|m.16085 | UnnamedSample_HQ_transcript/60120 | Coverage 0.322 too low. | 6c38b90daa1408edf999bdc1eea80558 | 527 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 438 | 514 | 4.4E-17 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/60120|m.16085 | UnnamedSample_HQ_transcript/60120 | Coverage 0.322 too low. | 6c38b90daa1408edf999bdc1eea80558 | 527 | Pfam | PF00501 | AMP-binding enzyme | 32 | 429 | 2.5E-84 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/63402|m.16712 | UnnamedSample_HQ_transcript/63402 | Coverage 0.318 too low. | 6c38b90daa1408edf999bdc1eea80558 | 527 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 438 | 514 | 4.4E-17 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/63402|m.16712 | UnnamedSample_HQ_transcript/63402 | Coverage 0.318 too low. | 6c38b90daa1408edf999bdc1eea80558 | 527 | Pfam | PF00501 | AMP-binding enzyme | 32 | 429 | 2.5E-84 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/65253|m.17070 | UnnamedSample_HQ_transcript/65253 | Coverage 0.300 too low. | 6c38b90daa1408edf999bdc1eea80558 | 527 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 438 | 514 | 4.4E-17 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/65253|m.17070 | UnnamedSample_HQ_transcript/65253 | Coverage 0.300 too low. | 6c38b90daa1408edf999bdc1eea80558 | 527 | Pfam | PF00501 | AMP-binding enzyme | 32 | 429 | 2.5E-84 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/39004|m.11630 | UnnamedSample_HQ_transcript/39004 | Identity 0.939 too low. | d0c131818c7df02bf58a28e63806b2bd | 715 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 20 | 702 | 3.8E-286 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/113847|m.24273 | UnnamedSample_HQ_transcript/113847 | Coverage 0.900 too low. | 71c9220ac0e9eb9468702979e4832bc6 | 211 | Pfam | PF00160 | Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD | 39 | 194 | 8.3E-49 | T | 22-09-2020 | IPR002130 | Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/105413|m.23276 | UnnamedSample_HQ_transcript/105413 | Coverage 0.769 too low. | 71c9220ac0e9eb9468702979e4832bc6 | 211 | Pfam | PF00160 | Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD | 39 | 194 | 8.3E-49 | T | 22-09-2020 | IPR002130 | Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/109364|m.23763 | UnnamedSample_HQ_transcript/109364 | Coverage 0.815 too low. | 71c9220ac0e9eb9468702979e4832bc6 | 211 | Pfam | PF00160 | Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD | 39 | 194 | 8.3E-49 | T | 22-09-2020 | IPR002130 | Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/37756|m.11337 | UnnamedSample_HQ_transcript/37756 | Coverage 0.729 too low. | 86d4519d014350e64c04f3e363020b25 | 370 | Pfam | PF00153 | Mitochondrial carrier protein | 163 | 246 | 1.3E-13 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/37756|m.11337 | UnnamedSample_HQ_transcript/37756 | Coverage 0.729 too low. | 86d4519d014350e64c04f3e363020b25 | 370 | Pfam | PF00153 | Mitochondrial carrier protein | 260 | 337 | 4.8E-9 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/37756|m.11337 | UnnamedSample_HQ_transcript/37756 | Coverage 0.729 too low. | 86d4519d014350e64c04f3e363020b25 | 370 | Pfam | PF00153 | Mitochondrial carrier protein | 65 | 146 | 1.5E-18 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/45295|m.12974 | UnnamedSample_HQ_transcript/45295 | Coverage 0.945 too low. | 28acf1a07b03861b46e4972cd5bc2e0a | 554 | Pfam | PF00245 | Alkaline phosphatase | 74 | 511 | 3.2E-132 | T | 22-09-2020 | IPR001952 | Alkaline phosphatase |
| UnnamedSample_HQ_transcript/49794|m.13979 | UnnamedSample_HQ_transcript/49794 | Coverage 0.946 too low. | 28acf1a07b03861b46e4972cd5bc2e0a | 554 | Pfam | PF00245 | Alkaline phosphatase | 74 | 511 | 3.2E-132 | T | 22-09-2020 | IPR001952 | Alkaline phosphatase |
| UnnamedSample_HQ_transcript/52619|m.14570 | UnnamedSample_HQ_transcript/52619 | Coverage 0.671 too low. | d0312f97b149a2cc806abc6af53b233d | 542 | Pfam | PF00135 | Carboxylesterase family | 20 | 535 | 3.4E-142 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/49128|m.13835 | UnnamedSample_HQ_transcript/49128 | Coverage 0.764 too low. | d0312f97b149a2cc806abc6af53b233d | 542 | Pfam | PF00135 | Carboxylesterase family | 20 | 535 | 3.4E-142 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/56746|m.15390 | UnnamedSample_HQ_transcript/56746 | Coverage 0.735 too low. | d0312f97b149a2cc806abc6af53b233d | 542 | Pfam | PF00135 | Carboxylesterase family | 20 | 535 | 3.4E-142 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/67112|m.17425 | UnnamedSample_HQ_transcript/67112 | Coverage 0.975 too low. | 1fbcbf704b7b769cda71c1aca114c28d | 296 | Pfam | PF00012 | Hsp70 protein | 1 | 294 | 2.0E-94 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/91054|m.21415 | UnnamedSample_HQ_transcript/91054 | Coverage 0.145 too low. | da62250c643c1e6dcba32f973d3e4749 | 402 | Pfam | PF00709 | Adenylosuccinate synthetase | 2 | 399 | 9.3E-167 | T | 22-09-2020 | IPR001114 | Adenylosuccinate synthetase |
| UnnamedSample_HQ_transcript/79327|m.19599 | UnnamedSample_HQ_transcript/79327 | Coverage 0.320 too low. | da62250c643c1e6dcba32f973d3e4749 | 402 | Pfam | PF00709 | Adenylosuccinate synthetase | 2 | 399 | 9.3E-167 | T | 22-09-2020 | IPR001114 | Adenylosuccinate synthetase |
| UnnamedSample_HQ_transcript/100999|m.22752 | UnnamedSample_HQ_transcript/100999 | Coverage 0.934 too low. | 341bf683a9354ddf51b028f5c1ba9567 | 262 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 154 | 200 | 0.017 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/100999|m.22752 | UnnamedSample_HQ_transcript/100999 | Coverage 0.934 too low. | 341bf683a9354ddf51b028f5c1ba9567 | 262 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 34 | 79 | 0.063 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/100999|m.22752 | UnnamedSample_HQ_transcript/100999 | Coverage 0.934 too low. | 341bf683a9354ddf51b028f5c1ba9567 | 262 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 216 | 261 | 0.0028 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/60858|m.16230 | UnnamedSample_HQ_transcript/60858 | Coverage 0.972 too low. | 277a178f19685dbc8b77f795f79a88b7 | 586 | Pfam | PF18358 | Histone methyltransferase Tudor domain | 476 | 525 | 9.7E-21 | T | 22-09-2020 | IPR041292 | Histone methyltransferase, Tudor domain 2 |
| UnnamedSample_HQ_transcript/60858|m.16230 | UnnamedSample_HQ_transcript/60858 | Coverage 0.972 too low. | 277a178f19685dbc8b77f795f79a88b7 | 586 | Pfam | PF18359 | Histone methyltransferase Tudor domain 1 | 384 | 437 | 8.9E-23 | T | 22-09-2020 | IPR041291 | Histone methyltransferase, Tudor domain 1 |
| UnnamedSample_HQ_transcript/1115|m.687 | UnnamedSample_HQ_transcript/1115 | Identity 0.941 too low. | 3cf9c7765f29c70f89b31e53413f1f3a | 1156 | Pfam | PF00094 | von Willebrand factor type D domain | 607 | 745 | 5.4E-7 | T | 22-09-2020 | IPR001846 | von Willebrand factor, type D domain |
| UnnamedSample_HQ_transcript/24132|m.7981 | UnnamedSample_HQ_transcript/24132 | Coverage 0.990 too low. | 45963d22acec7ada0f1465da1a309eed | 934 | Pfam | PF02992 | Transposase family tnp2 | 343 | 482 | 7.2E-7 | T | 22-09-2020 | IPR004242 | Transposon, En/Spm-like |
| UnnamedSample_HQ_transcript/33842|m.10421 | UnnamedSample_HQ_transcript/33842 | Coverage 0.987 too low. | e42f0217b9dc17183c4bf37d66fb3375 | 664 | Pfam | PF01061 | ABC-2 type transporter | 368 | 577 | 1.7E-21 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/33842|m.10421 | UnnamedSample_HQ_transcript/33842 | Coverage 0.987 too low. | e42f0217b9dc17183c4bf37d66fb3375 | 664 | Pfam | PF00005 | ABC transporter | 75 | 219 | 5.0E-29 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/2634|m.1290 | UnnamedSample_HQ_transcript/2634 | Identity 0.657 too low. | 96fdb7009793bfb9c770cee24d22f74c | 1151 | Pfam | PF00621 | RhoGEF domain | 759 | 945 | 6.2E-37 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/79038|m.19554 | UnnamedSample_HQ_transcript/79038 | Coverage 0.811 too low. | 72eac1404326a050568442d8a6646726 | 294 | Pfam | PF00373 | FERM central domain | 149 | 256 | 1.5E-15 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/79038|m.19554 | UnnamedSample_HQ_transcript/79038 | Coverage 0.811 too low. | 72eac1404326a050568442d8a6646726 | 294 | Pfam | PF09379 | FERM N-terminal domain | 69 | 129 | 1.5E-19 | T | 22-09-2020 | IPR018979 | FERM, N-terminal |
| UnnamedSample_HQ_transcript/87748|m.20899 | UnnamedSample_HQ_transcript/87748 | Coverage 0.983 too low. | d61846efb569e951c64ea5cab023435a | 339 | Pfam | PF03781 | Sulfatase-modifying factor enzyme 1 | 58 | 335 | 3.4E-76 | T | 22-09-2020 | IPR005532 | Sulfatase-modifying factor enzyme |
| UnnamedSample_HQ_transcript/116536|m.24539 | UnnamedSample_HQ_transcript/116536 | Coverage 0.987 too low. | 99b70c840f04b50da0e922bbe65aa895 | 115 | Pfam | PF07679 | Immunoglobulin I-set domain | 2 | 60 | 6.6E-9 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3555|m.1638 | UnnamedSample_HQ_transcript/3555 | Coverage 0.536 too low. | e8bd2fccb542e7207df3741792d9ac25 | 494 | Pfam | PF00535 | Glycosyl transferase family 2 | 190 | 372 | 4.9E-34 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/19294|m.6665 | UnnamedSample_HQ_transcript/19294 | Coverage 0.384 too low. | 009d7fc05d001574857c63c70989f29d | 862 | Pfam | PF03451 | HELP motif | 229 | 301 | 1.2E-31 | T | 22-09-2020 | IPR005108 | HELP |
| UnnamedSample_HQ_transcript/19294|m.6665 | UnnamedSample_HQ_transcript/19294 | Coverage 0.384 too low. | 009d7fc05d001574857c63c70989f29d | 862 | Pfam | PF00400 | WD domain, G-beta repeat | 824 | 860 | 0.025 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/19294|m.6665 | UnnamedSample_HQ_transcript/19294 | Coverage 0.384 too low. | 009d7fc05d001574857c63c70989f29d | 862 | Pfam | PF00400 | WD domain, G-beta repeat | 665 | 700 | 0.054 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/19294|m.6665 | UnnamedSample_HQ_transcript/19294 | Coverage 0.384 too low. | 009d7fc05d001574857c63c70989f29d | 862 | Pfam | PF00400 | WD domain, G-beta repeat | 305 | 350 | 2.4E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/19294|m.6665 | UnnamedSample_HQ_transcript/19294 | Coverage 0.384 too low. | 009d7fc05d001574857c63c70989f29d | 862 | Pfam | PF00400 | WD domain, G-beta repeat | 712 | 747 | 0.004 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/82015|m.20032 | UnnamedSample_HQ_transcript/82015 | Coverage 0.617 too low. | 063abb6a994303eb1f9c6bf50005334a | 306 | Pfam | PF01061 | ABC-2 type transporter | 105 | 243 | 4.2E-32 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/82015|m.20032 | UnnamedSample_HQ_transcript/82015 | Coverage 0.617 too low. | 063abb6a994303eb1f9c6bf50005334a | 306 | Pfam | PF01061 | ABC-2 type transporter | 1 | 74 | 8.2E-9 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/67937|m.17568 | UnnamedSample_HQ_transcript/67937 | Coverage 0.989 too low. | 6204ca2b6f2e5888de0ec4871c435b84 | 481 | Pfam | PF00651 | BTB/POZ domain | 345 | 442 | 3.9E-19 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/67937|m.17568 | UnnamedSample_HQ_transcript/67937 | Coverage 0.989 too low. | 6204ca2b6f2e5888de0ec4871c435b84 | 481 | Pfam | PF13540 | Regulator of chromosome condensation (RCC1) repeat | 205 | 234 | 2.5E-5 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/67937|m.17568 | UnnamedSample_HQ_transcript/67937 | Coverage 0.989 too low. | 6204ca2b6f2e5888de0ec4871c435b84 | 481 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 87 | 136 | 9.5E-15 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/15551|m.5568 | UnnamedSample_HQ_transcript/15551 | Coverage 0.926 too low. | e4d4ecc53f360cdc95d938da450b8ab3 | 114 | Pfam | PF00389 | D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain | 39 | 110 | 9.8E-14 | T | 22-09-2020 | IPR006139 | D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain |
| UnnamedSample_HQ_transcript/89658|m.21186 | UnnamedSample_HQ_transcript/89658 | Coverage 0.703 too low. | 13a25b0eb530db93f7a83b6f3851f72a | 389 | Pfam | PF00107 | Zinc-binding dehydrogenase | 188 | 317 | 1.1E-13 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/89658|m.21186 | UnnamedSample_HQ_transcript/89658 | Coverage 0.703 too low. | 13a25b0eb530db93f7a83b6f3851f72a | 389 | Pfam | PF08240 | Alcohol dehydrogenase GroES-like domain | 65 | 126 | 1.5E-13 | T | 22-09-2020 | IPR013154 | Alcohol dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/51638|m.14380 | UnnamedSample_HQ_transcript/51638 | Coverage 0.731 too low. | 744f5d9c868f0c08cd8cee4023aec8c7 | 288 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 49 | 123 | 3.8E-6 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/23840|m.7899 | UnnamedSample_HQ_transcript/23840 | Coverage 0.928 too low. | 12fb303ca4e41827c79025a2910e92e8 | 955 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 337 | 376 | 3.1E-9 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/23840|m.7899 | UnnamedSample_HQ_transcript/23840 | Coverage 0.928 too low. | 12fb303ca4e41827c79025a2910e92e8 | 955 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 595 | 630 | 5.3E-6 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/23840|m.7899 | UnnamedSample_HQ_transcript/23840 | Coverage 0.928 too low. | 12fb303ca4e41827c79025a2910e92e8 | 955 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 381 | 422 | 1.1E-6 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/23840|m.7899 | UnnamedSample_HQ_transcript/23840 | Coverage 0.928 too low. | 12fb303ca4e41827c79025a2910e92e8 | 955 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 638 | 675 | 9.9E-6 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/117598|m.24650 | UnnamedSample_HQ_transcript/117598 | Unmapped. | b6856cc6eef7496ef2d511d7ae3f1b57 | 138 | Pfam | PF00011 | Hsp20/alpha crystallin family | 43 | 138 | 1.4E-18 | T | 22-09-2020 | IPR002068 | Alpha crystallin/Hsp20 domain |
| UnnamedSample_HQ_transcript/115905|m.24484 | UnnamedSample_HQ_transcript/115905 | Unmapped. | b6856cc6eef7496ef2d511d7ae3f1b57 | 138 | Pfam | PF00011 | Hsp20/alpha crystallin family | 43 | 138 | 1.4E-18 | T | 22-09-2020 | IPR002068 | Alpha crystallin/Hsp20 domain |
| UnnamedSample_HQ_transcript/104048|m.23112 | UnnamedSample_HQ_transcript/104048 | Unmapped. | b6856cc6eef7496ef2d511d7ae3f1b57 | 138 | Pfam | PF00011 | Hsp20/alpha crystallin family | 43 | 138 | 1.4E-18 | T | 22-09-2020 | IPR002068 | Alpha crystallin/Hsp20 domain |
| UnnamedSample_HQ_transcript/110175|m.23864 | UnnamedSample_HQ_transcript/110175 | Unmapped. | b6856cc6eef7496ef2d511d7ae3f1b57 | 138 | Pfam | PF00011 | Hsp20/alpha crystallin family | 43 | 138 | 1.4E-18 | T | 22-09-2020 | IPR002068 | Alpha crystallin/Hsp20 domain |
| UnnamedSample_HQ_transcript/20625|m.7041 | UnnamedSample_HQ_transcript/20625 | Coverage 0.623 too low. | 08f07c4c9015489c53dda1d966061323 | 559 | Pfam | PF14051 | N-terminal domain of DPF2/REQ. | 25 | 95 | 5.1E-36 | T | 22-09-2020 | IPR025750 | Requiem/DPF N-terminal domain |
| UnnamedSample_HQ_transcript/20625|m.7041 | UnnamedSample_HQ_transcript/20625 | Coverage 0.623 too low. | 08f07c4c9015489c53dda1d966061323 | 559 | Pfam | PF00628 | PHD-finger | 508 | 554 | 9.2E-13 | T | 22-09-2020 | IPR019787 | Zinc finger, PHD-finger |
| UnnamedSample_HQ_transcript/52211|m.14490 | UnnamedSample_HQ_transcript/52211 | Coverage 0.837 too low. | 08f07c4c9015489c53dda1d966061323 | 559 | Pfam | PF14051 | N-terminal domain of DPF2/REQ. | 25 | 95 | 5.1E-36 | T | 22-09-2020 | IPR025750 | Requiem/DPF N-terminal domain |
| UnnamedSample_HQ_transcript/52211|m.14490 | UnnamedSample_HQ_transcript/52211 | Coverage 0.837 too low. | 08f07c4c9015489c53dda1d966061323 | 559 | Pfam | PF00628 | PHD-finger | 508 | 554 | 9.2E-13 | T | 22-09-2020 | IPR019787 | Zinc finger, PHD-finger |
| UnnamedSample_HQ_transcript/49058|m.13813 | UnnamedSample_HQ_transcript/49058 | Coverage 0.456 too low. | 08f07c4c9015489c53dda1d966061323 | 559 | Pfam | PF14051 | N-terminal domain of DPF2/REQ. | 25 | 95 | 5.1E-36 | T | 22-09-2020 | IPR025750 | Requiem/DPF N-terminal domain |
| UnnamedSample_HQ_transcript/49058|m.13813 | UnnamedSample_HQ_transcript/49058 | Coverage 0.456 too low. | 08f07c4c9015489c53dda1d966061323 | 559 | Pfam | PF00628 | PHD-finger | 508 | 554 | 9.2E-13 | T | 22-09-2020 | IPR019787 | Zinc finger, PHD-finger |
| UnnamedSample_HQ_transcript/58692|m.15793 | UnnamedSample_HQ_transcript/58692 | Coverage 0.916 too low. | 08f07c4c9015489c53dda1d966061323 | 559 | Pfam | PF14051 | N-terminal domain of DPF2/REQ. | 25 | 95 | 5.1E-36 | T | 22-09-2020 | IPR025750 | Requiem/DPF N-terminal domain |
| UnnamedSample_HQ_transcript/58692|m.15793 | UnnamedSample_HQ_transcript/58692 | Coverage 0.916 too low. | 08f07c4c9015489c53dda1d966061323 | 559 | Pfam | PF00628 | PHD-finger | 508 | 554 | 9.2E-13 | T | 22-09-2020 | IPR019787 | Zinc finger, PHD-finger |
| UnnamedSample_HQ_transcript/23195|m.7736 | UnnamedSample_HQ_transcript/23195 | Coverage 0.638 too low. | 08f07c4c9015489c53dda1d966061323 | 559 | Pfam | PF14051 | N-terminal domain of DPF2/REQ. | 25 | 95 | 5.1E-36 | T | 22-09-2020 | IPR025750 | Requiem/DPF N-terminal domain |
| UnnamedSample_HQ_transcript/23195|m.7736 | UnnamedSample_HQ_transcript/23195 | Coverage 0.638 too low. | 08f07c4c9015489c53dda1d966061323 | 559 | Pfam | PF00628 | PHD-finger | 508 | 554 | 9.2E-13 | T | 22-09-2020 | IPR019787 | Zinc finger, PHD-finger |
| UnnamedSample_HQ_transcript/53745|m.14793 | UnnamedSample_HQ_transcript/53745 | Coverage 0.435 too low. | 5eeaa7cf7a50a2ed5d4d98d1b20caa7f | 701 | Pfam | PF00078 | Reverse transcriptase (RNA-dependent DNA polymerase) | 201 | 448 | 2.1E-44 | T | 22-09-2020 | IPR000477 | Reverse transcriptase domain |
| UnnamedSample_HQ_transcript/32952|m.10198 | UnnamedSample_HQ_transcript/32952 | Coverage 0.989 too low. | a95a3dc362820755ea30cc97c2ce65e5 | 433 | Pfam | PF00069 | Protein kinase domain | 304 | 423 | 1.1E-23 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/65706|m.17148 | UnnamedSample_HQ_transcript/65706 | Coverage 0.973 too low. | 3659f2bb192d2d442944d87daf6614db | 439 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 46 | 114 | 5.6E-13 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/65706|m.17148 | UnnamedSample_HQ_transcript/65706 | Coverage 0.973 too low. | 3659f2bb192d2d442944d87daf6614db | 439 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 284 | 346 | 1.5E-17 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/65706|m.17148 | UnnamedSample_HQ_transcript/65706 | Coverage 0.973 too low. | 3659f2bb192d2d442944d87daf6614db | 439 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 173 | 238 | 5.6E-13 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/65706|m.17148 | UnnamedSample_HQ_transcript/65706 | Coverage 0.973 too low. | 3659f2bb192d2d442944d87daf6614db | 439 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 398 | 438 | 3.6E-7 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/11564|m.4343 | UnnamedSample_HQ_transcript/11564 | Coverage 0.819 too low. | 2a37ac493bd1f3163a4065e40b5ec9e2 | 289 | Pfam | PF00651 | BTB/POZ domain | 125 | 225 | 2.8E-31 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/9314|m.3612 | UnnamedSample_HQ_transcript/9314 | Unmapped. | 50f317886b76266606aab8d202b218e8 | 1334 | Pfam | PF13086 | AAA domain | 269 | 339 | 6.3E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/9314|m.3612 | UnnamedSample_HQ_transcript/9314 | Unmapped. | 50f317886b76266606aab8d202b218e8 | 1334 | Pfam | PF13087 | AAA domain | 452 | 623 | 1.1E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/1332|m.779 | UnnamedSample_HQ_transcript/1332 | Coverage 0.959 too low. | 6c2ff3a190631b7ea65d7e17dd2ddb86 | 1360 | Pfam | PF00626 | Gelsolin repeat | 895 | 986 | 5.6E-6 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/1332|m.779 | UnnamedSample_HQ_transcript/1332 | Coverage 0.959 too low. | 6c2ff3a190631b7ea65d7e17dd2ddb86 | 1360 | Pfam | PF02209 | Villin headpiece domain | 1325 | 1360 | 6.3E-14 | T | 22-09-2020 | IPR003128 | Villin headpiece |
| UnnamedSample_HQ_transcript/34810|m.10676 | UnnamedSample_HQ_transcript/34810 | Coverage 0.927 too low. | 93b6ada489f77ff792c9d7d72269984d | 398 | Pfam | PF00405 | Transferrin | 48 | 324 | 7.4E-17 | T | 22-09-2020 | IPR001156 | Transferrin-like domain |
| UnnamedSample_HQ_transcript/25132|m.8251 | UnnamedSample_HQ_transcript/25132 | Coverage 0.976 too low. | 736abe27a2e0169ea25ea8f6fb38e4fb | 543 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 419 | 472 | 1.4E-11 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/55110|m.15060 | UnnamedSample_HQ_transcript/55110 | Coverage 0.985 too low. | 2dd869926fcdc228d75cb65b00b2e081 | 619 | Pfam | PF00171 | Aldehyde dehydrogenase family | 188 | 488 | 1.9E-10 | T | 22-09-2020 | IPR015590 | Aldehyde dehydrogenase domain |
| UnnamedSample_HQ_transcript/55110|m.15060 | UnnamedSample_HQ_transcript/55110 | Coverage 0.985 too low. | 2dd869926fcdc228d75cb65b00b2e081 | 619 | Pfam | PF00696 | Amino acid kinase family | 2 | 161 | 3.7E-26 | T | 22-09-2020 | IPR001048 | Aspartate/glutamate/uridylate kinase |
| UnnamedSample_HQ_transcript/66185|m.17247 | UnnamedSample_HQ_transcript/66185 | Coverage 0.086 too low. | 49f3a7d0af6f070e8754fa8780ee65fe | 453 | Pfam | PF00089 | Trypsin | 202 | 420 | 3.4E-43 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/66185|m.17247 | UnnamedSample_HQ_transcript/66185 | Coverage 0.086 too low. | 49f3a7d0af6f070e8754fa8780ee65fe | 453 | Pfam | PF16030 | Serine protease gd N-terminus | 24 | 130 | 4.8E-16 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/120605|m.24890 | UnnamedSample_HQ_transcript/120605 | Coverage 0.650 too low. | 721c873caa20ffc3e2c877fdc4ea8c55 | 205 | Pfam | PF00069 | Protein kinase domain | 1 | 185 | 5.3E-42 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/16126|m.5749 | UnnamedSample_HQ_transcript/16126 | Coverage 0.939 too low. | b22cc0ff32fd9bec311e6866f2419f65 | 476 | Pfam | PF00083 | Sugar (and other) transporter | 2 | 450 | 4.7E-130 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/16673|m.5910 | UnnamedSample_HQ_transcript/16673 | Coverage 0.066 too low. | 10a78f74d6a4893782fb956d33b1cb05 | 624 | Pfam | PF00581 | Rhodanese-like domain | 466 | 572 | 2.1E-14 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/51272|m.14298 | UnnamedSample_HQ_transcript/51272 | Coverage 0.429 too low. | 8be1f3411326cd8b347d32677d0d3539 | 543 | Pfam | PF18100 | Phosphodiesterase 4 upstream conserved regions (UCR) | 189 | 307 | 9.3E-54 | T | 22-09-2020 | IPR040844 | Phosphodiesterase 4 upstream conserved regions (UCR) |
| UnnamedSample_HQ_transcript/51272|m.14298 | UnnamedSample_HQ_transcript/51272 | Coverage 0.429 too low. | 8be1f3411326cd8b347d32677d0d3539 | 543 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 449 | 542 | 4.4E-38 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/25330|m.8294 | UnnamedSample_HQ_transcript/25330 | Coverage 0.839 too low. | 74a202b3f13266576d3b990237642dca | 499 | Pfam | PF03098 | Animal haem peroxidase | 1 | 466 | 1.0E-167 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
